HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Luigi Iannaccone Selected Research

Myocardial Infarction

10/2018Predictive Value of Oxidized Low-Density Lipoprotein/β2-Glycoprotein-I Complexes (oxLDL/β2GPI) in Nonautoimmune Atherothrombosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Luigi Iannaccone Research Topics

Disease

11Thrombosis (Thrombus)
03/2024 - 04/2005
6Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
02/2021 - 06/2005
3Hypertension (High Blood Pressure)
06/2023 - 09/2021
3Liver Cirrhosis (Hepatic Cirrhosis)
01/2023 - 02/2006
3Atherosclerosis
10/2018 - 01/2008
3Thrombophilia
06/2011 - 06/2005
2Liver Diseases (Liver Disease)
01/2023 - 05/2004
2Ischemic Stroke
08/2022 - 10/2018
2Venous Thromboembolism
09/2021 - 10/2018
2Hemorrhage
03/2015 - 11/2007
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
12/2010 - 01/2008
2Venous Thrombosis (Deep-Vein Thrombosis)
03/2008 - 06/2007
2Activated Protein C Resistance (APC Resistance)
06/2004 - 03/2003
1Retinal Vein Occlusion
01/2024
1Obesity
06/2023
1Migraine Disorders (Migraine)
08/2022
1Myocardial Infarction
10/2018
1Peripheral Vascular Diseases (Peripheral Vascular Disease)
10/2018
1Hemophilia A (Haemophilia)
03/2015
1Fibrosis (Cirrhosis)
08/2011
1Coumarin Resistance
06/2011
1Arterial Occlusive Diseases (Arterial Occlusive Disease)
12/2010

Drug/Important Bio-Agent (IBA)

6Antiphospholipid AntibodiesIBA
02/2021 - 06/2005
5Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA
03/2024 - 08/2022
5Prothrombin (Factor II)IBA
03/2024 - 05/2004
4HomocysteineIBA
03/2024 - 09/2021
4Immunoglobulin G (IgG)IBA
08/2011 - 04/2005
2Protein CIBA
01/2023 - 06/2004
2AnticoagulantsIBA
01/2023 - 11/2007
2FibrinIBA
06/2011 - 06/2005
2factor V LeidenIBA
06/2007 - 03/2003
2Factor V (Coagulation Factor V)IBA
06/2004 - 03/2003
1Oxidoreductases (Dehydrogenase)IBA
09/2021
1EnzymesIBA
09/2021
1ThrombinFDA Link
07/2019
1AntithrombinsIBA
07/2019
1N 30IBA
10/2018
1oxidized low density lipoproteinIBA
10/2018
1Glycoproteins (Glycoprotein)IBA
10/2018
1LipidsIBA
10/2018
1AntibodiesIBA
03/2015
1Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA
03/2015
1Factor IX (Coagulation Factor IX)FDA LinkGeneric
03/2015
1Factor VIII (Coagulation Factor VIII)IBA
03/2015
1Phospholipids (Phosphatides)FDA LinkGeneric
08/2011
1Warfarin (Coumadin)FDA LinkGeneric
06/2011
1Cytochrome P-450 CYP2C9IBA
06/2011
1Anticardiolipin AntibodiesIBA
06/2011
1Vitamin K Epoxide ReductasesIBA
06/2011
1CytochromesIBA
06/2011
1NitritesIBA
12/2010
1Nitric Oxide (Nitrogen Monoxide)FDA Link
12/2010
1NitratesIBA
12/2010
1Oral ContraceptivesIBA
03/2008
1Factor XIII (Coagulation Factor XIII)IBA
06/2005
1Fibrinogen (Factor I)FDA Link
06/2005
1Proteins (Proteins, Gene)FDA Link
06/2004

Therapy/Procedure

1Therapeutics
11/2007
1Prostheses and Implants (Prosthesis)
06/2005